PROS1 and cancer: Given the key role of the ubiquitin–proteasome system in controlling the degradation of various bone-related proteins and the importance of regulatory ubiquitination in cancer metastasis [246,247], focus has been drawn to the potential use of proteasome inhibitors for the improvement of bone anabolism [248].